![Simple linear measurements of the normal liver: interobserver agreement and correlation with hepatic volume on MRI. | Semantic Scholar Simple linear measurements of the normal liver: interobserver agreement and correlation with hepatic volume on MRI. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3d0637370bb33fe0650001c454aadc0a13199d14/11-Table1-1.png)
Simple linear measurements of the normal liver: interobserver agreement and correlation with hepatic volume on MRI. | Semantic Scholar
![Preclinical evaluation of FLT190, a liver-directed AAV gene therapy for Fabry disease | Gene Therapy Preclinical evaluation of FLT190, a liver-directed AAV gene therapy for Fabry disease | Gene Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41434-022-00381-y/MediaObjects/41434_2022_381_Fig1_HTML.png)
Preclinical evaluation of FLT190, a liver-directed AAV gene therapy for Fabry disease | Gene Therapy
![Discovery of 2-[3,5-Dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β Agonist in Clinical Trials for the Treatment of ... Discovery of 2-[3,5-Dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β Agonist in Clinical Trials for the Treatment of ...](https://pubs.acs.org/cms/10.1021/jm4019299/asset/images/large/jm-2013-019299_0014.jpeg)
Discovery of 2-[3,5-Dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β Agonist in Clinical Trials for the Treatment of ...
Turning the Page: Advancing Paper-Based Microfluidics for Broad Diagnostic Application | Chemical Reviews
![PDF) Fibrinogen measurement in liver disease: Validation of the functional fibrinogen thromboelastography assay and a novel mathematical predictive model PDF) Fibrinogen measurement in liver disease: Validation of the functional fibrinogen thromboelastography assay and a novel mathematical predictive model](https://i1.rgstatic.net/publication/328873338_Fibrinogen_measurement_in_liver_disease_validation_of_the_functional_fibrinogen_thromboelastography_assay_and_a_novel_mathematical_predictive_model/links/5bf30ec5299bf1124fde5de4/largepreview.png)
PDF) Fibrinogen measurement in liver disease: Validation of the functional fibrinogen thromboelastography assay and a novel mathematical predictive model
![Multi-organ imaging demonstrates the heart-brain-liver axis in UK Biobank participants | Nature Communications Multi-organ imaging demonstrates the heart-brain-liver axis in UK Biobank participants | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-022-35321-2/MediaObjects/41467_2022_35321_Fig1_HTML.png)
Multi-organ imaging demonstrates the heart-brain-liver axis in UK Biobank participants | Nature Communications
![Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis - The Lancet Gastroenterology & Hepatology Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/asset/84760eb9-adf3-4cc1-aafd-8f7c56c343fc/gr1.jpg)
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis - The Lancet Gastroenterology & Hepatology
![Rhesus monkey model of liver disease reflecting clinical disease progression and hepatic gene expression analysis | Scientific Reports Rhesus monkey model of liver disease reflecting clinical disease progression and hepatic gene expression analysis | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep15019/MediaObjects/41598_2015_Article_BFsrep15019_Fig1_HTML.jpg)
Rhesus monkey model of liver disease reflecting clinical disease progression and hepatic gene expression analysis | Scientific Reports
Liver-Targeted siRNA Lipid Nanoparticles Treat Hepatic Cirrhosis by Dual Antifibrotic and Anti-inflammatory Activities | ACS Nano
![PDF] A natural 4-parameter family of covariance functions for stationary Gaussian processes | Semantic Scholar PDF] A natural 4-parameter family of covariance functions for stationary Gaussian processes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c08c71ffe13c0999a23cd6d50d52dd959217ec17/5-Figure1-1.png)
PDF] A natural 4-parameter family of covariance functions for stationary Gaussian processes | Semantic Scholar
![Hepatic expression of GAA results in enhanced enzyme bioavailability in mice and non-human primates | Nature Communications Hepatic expression of GAA results in enhanced enzyme bioavailability in mice and non-human primates | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-26744-4/MediaObjects/41467_2021_26744_Fig1_HTML.png)
Hepatic expression of GAA results in enhanced enzyme bioavailability in mice and non-human primates | Nature Communications
![Development and validation of an ensemble machine learning framework for detection of all-cause advanced hepatic fibrosis: a retrospective cohort study - The Lancet Digital Health Development and validation of an ensemble machine learning framework for detection of all-cause advanced hepatic fibrosis: a retrospective cohort study - The Lancet Digital Health](https://www.thelancet.com/cms/attachment/ee8ba9fe-d1c8-4d3d-b9ed-d8d840c8d9a4/gr1.gif)
Development and validation of an ensemble machine learning framework for detection of all-cause advanced hepatic fibrosis: a retrospective cohort study - The Lancet Digital Health
![Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Gastroenterology & Hepatology Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/attachment/5aebde50-2aa2-42f9-8bcf-7f749b942b0b/gr1.jpg)
Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Gastroenterology & Hepatology
![Identifying disease-critical cell types and cellular processes by integrating single-cell RNA-sequencing and human genetics | Nature Genetics Identifying disease-critical cell types and cellular processes by integrating single-cell RNA-sequencing and human genetics | Nature Genetics](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41588-022-01187-9/MediaObjects/41588_2022_1187_Fig1_HTML.png)
Identifying disease-critical cell types and cellular processes by integrating single-cell RNA-sequencing and human genetics | Nature Genetics
![A targetable LIFR−NF-κB−LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis | Nature Communications A targetable LIFR−NF-κB−LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-021-27452-9/MediaObjects/41467_2021_27452_Fig1_HTML.png)